SGLT2 Inhibitors in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Translational Synthesis From Molecular Pathways to Clinical Potential

Scritto il 26/06/2026
da Mislav Radić

No abstract

Int J Rheum Dis. 2026 Jul;29(7):e70747. doi: 10.1111/1756-185x.70747.

NO ABSTRACT

PMID:42363023 | DOI:10.1111/1756-185x.70747